All Stories

  1. JAK2, 46/1 haplotype and chronic myelogenous leukemia: diagnostic and therapeutic potential

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), December 2019, De Gruyter

    Matteo Basilio Suter

  2. Metabolic tumour volume and response to therapy in diffuse large B‐cell lymphoma

    Article • Hematological Oncology, April 2019, Wiley

    Matteo Basilio Suter

  3. Germline Predisposition and Copy Number Alteration in Pre-stage Lung Adenocarcinomas Presenting as Ground-Glass Nodules

    Article • Frontiers in Oncology, April 2019, Frontiers

    Matteo Basilio Suter

  4. Long-term therapy with bevacizumab in a young patient affected by NF-2

    Article • Anti-Cancer Drugs, March 2019, Wolters Kluwer Health

    Matteo Basilio Suter

  5. Imaging of distant metastases of prostate cancer

    Article • Medical Oncology, September 2018, Springer Science + Business Media

    Matteo Basilio Suter

  6. Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatments

    Article • Future Oncology, May 2018, Future Medicine

    Matteo Basilio Suter

  7. Should age impact breast cancer management in young women? Fine tuning of treatment guidelines

    Article • Therapeutic Advances in Medical Oncology, January 2018, SAGE Publications

    Matteo Basilio Suter

  8. PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis

    Article • Internal and Emergency Medicine, July 2017, Springer Science + Business Media

    Matteo Basilio Suter

  9. Colitis and chronic bleeding in patients treated with dasatinib

    Article • Journal of Cancer Research & Therapy, June 2017, Noble Research Publishers

    Matteo Basilio Suter

  10. Biopsy and re-biopsy in lung cancer: the oncologist requests and the role of endobronchial ultrasounds transbronchial needle aspiration

    Article • Journal of Thoracic Disease, May 2017, AME Publishing Company

    Matteo Basilio Suter

  11. Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis

    Article • European Journal of Cancer, May 2017, Elsevier

    Matteo Basilio Suter

  12. Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports

    Article • Future Oncology, April 2015, Future Medicine

    Matteo Basilio Suter

  13. Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors

    Article • European Journal of Cancer, March 2013, Elsevier

    Matteo Basilio Suter